CBUS.NASDAQCibus, INC

SCHEDULE 13G: Armistice Capital and Steven Boyd Disclose 5.97% Passive Stake in Cibus, Inc.

Sentiment:

Beneficial Ownership Disclosure


Armistice Capital, LLC and Steven Boyd have jointly reported a passive beneficial ownership of 5.97% in Cibus, Inc.'s Class A Common Stock, totaling 1,948,000 shares.

Summary

  • Armistice Capital, LLC and Steven Boyd, collectively referred to as the "Reporting Persons," have filed a Schedule 13G indicating beneficial ownership of Cibus, Inc.'s Class A Common Stock.
  • The Reporting Persons beneficially own an aggregate of 1,948,000 shares of Cibus, Inc. Class A Common Stock.
  • This ownership represents 5.97% of the total Class A Common Stock outstanding.
  • The percentage is calculated based on 32,638,411 shares outstanding as of March 19, 2025, as reported in Cibus, Inc.'s Form 10-K filed on March 20, 2025.
  • Armistice Capital, LLC, a Delaware entity, acts as the investment manager for Armistice Capital Master Fund Ltd., which is the direct holder of the shares.
  • Steven Boyd, a U.S. citizen, is the managing member of Armistice Capital, LLC and is deemed to beneficially own the shares held by the Master Fund.
  • The filing indicates that the shares were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing the control of the issuer.

Sentiment

Score: 5

Explanation: The document is a factual regulatory filing disclosing beneficial ownership. It does not contain qualitative information or performance metrics that would typically lead to a strong positive or negative sentiment. The disclosure of a significant stake by an institutional investor is generally neutral to slightly positive, indicating investor interest.

Positives

  • The disclosure of a significant stake (5.97%) by an institutional investor like Armistice Capital, LLC and its managing member Steven Boyd, may be viewed as a vote of confidence in Cibus, Inc. by these sophisticated investors.

Future Outlook

The document is a beneficial ownership disclosure and does not contain any forward-looking statements or guidance regarding the issuer's future performance or strategic direction.

Management Comments

  • The Reporting Persons certify that, to the best of their knowledge and belief, the securities were acquired and are held in the ordinary course of business.
  • The Reporting Persons certify that the securities were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of Cibus, Inc.

Industry Context

This Schedule 13G filing is a standard regulatory disclosure of a significant passive investment. It does not provide specific insights into broader industry trends or competitive landscape, but rather reflects an investment decision by a specific fund within the biotechnology or agricultural technology sector where Cibus, Inc. operates.

Stakeholder Impact

  • Shareholders: The disclosure informs existing and potential shareholders about a significant institutional investor's stake, which can influence market perception and trading activity.

Key Dates

DateDescription
03/19/2025Date as of which 32,638,411 shares of Class A Common Stock were outstanding, used for percentage calculation.
03/20/2025Date Cibus, Inc. filed its Form 10-K with the SEC, reporting the shares outstanding.
03/31/2025Date of event which required the filing of this Schedule 13G statement.
05/15/2025Date the Schedule 13G was signed and filed by Armistice Capital, LLC and Steven Boyd.

Keywords

Cibus Inc., Armistice Capital, Steven Boyd, Schedule 13G, beneficial ownership, Class A Common Stock, passive investment, institutional investor, SEC filing

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.